38227 Insurance Policy Changes

CPT 38227, in plain terms, covers A medical facility receives and prepares CAR-T cells (specially engineered immune cells) for treatment administration to a patient. CPT 38227 is referenced in 20 tracked payer policy changes from Aetna, Independence Blue Cross, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 38227 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Official descriptor: CPT 38227 on AAPC